Xavier Roussel
Besancon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Mature plasmacytoid dendritic cell proliferations are also associated with T-cell acute lymphoblastic leukemia: towards an expanding range of associated neoplasms.
Journal: Haematologica
Published: May 04, 2026
A Subset of Pro-inflammatory CXCL10+ LILRB2+ Macrophages Derives From Recipient Monocytes and Drives Renal Allograft Rejection.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 24, 2025
Pivekimab sunirine in blastic plasmacytoid dendritic cell neoplasm: assessing spatial response and unraveling resistance mechanisms.
Journal: Haematologica
Published: July 10, 2025
Evaluation of dasatinib and ponatinib for the control of CD123 CAR-T cell functionalities.
Journal: Molecular therapy. Oncology
Published: June 13, 2025
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia.
Journal: Leukemia
Published: June 03, 2025
New leads to enhance tagraxofusp efficacy in pDC-AML.
Journal: Blood neoplasia
Published: October 28, 2024
Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Journal: The Journal of infection
Published: February 12, 2024
Long-term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO).
Journal: British journal of haematology
Published: December 04, 2023
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.
Journal: Cancer immunology research
Published: July 10, 2023
CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.
Journal: Current research in translational medicine
Published: July 18, 2022
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Journal: Journal for immunotherapy of cancer
Published: June 27, 2022
Last Updated: 09/26/2026